Literature DB >> 4892322

A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus pas.

C V Ramakrishnan, S Devadatta, C Evans, W Fox, N K Menon, O Nazareth, S Radhakrishna, S Sambamoorthy, H Stott, S P Tripathy, S Velu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4892322     DOI： 10.1016/0041-3879(69)90018-x

Source DB:  PubMed          Journal:  Tubercle        ISSN： 0041-3879


× No keyword cloud information.
  8 in total

Review 1.  Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors:  W J Burman; K Gallicano; C Peloquin
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 2. Second report: the results from 12 to 24 months.

Authors: 
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

Review 3.  [Results of chemotherapy in tuberculosis].

Authors:  E Jancik
Journal:  Pneumonologie       Date:  1971

4.  Tuberculous infection.

Authors:  D A Mitchison
Journal:  Proc R Soc Med       Date:  1971-05

5.  Potentially serious side-effects of high-dose twice-weekly rifampicin.

Authors:  G Poole; P Stradling; S Worlledge
Journal:  Postgrad Med J       Date:  1971-11       Impact factor: 2.401

6.  A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis.

Authors: 
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

7.  Potentially serious side effects of high-dose twice-weekly rifampicin.

Authors:  G Poole; P Stradling; S Worlledge
Journal:  Br Med J       Date:  1971-08-07

8.  Controlled comparison of oral twice-weekly and oral daily isoniazid plus PAS in newly diagnosed pulmonary tuberculosis.

Authors: 
Journal:  Br Med J       Date:  1973-04-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.